Tower Bridge Advisors
Source: SEC Form 13F · as of Mar 2026Tower Bridge Advisors holds 12 biotech & pharma companies tracked by BioSniper, totaling $78.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$78.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 89,249 | $21.8M |
| IQVIQVIA Holdings Inc. | 66,262 | $11.3M |
| NVSNovartis AG | 71,531 | $10.9M |
| ABBVAbbVie Inc. | 39,323 | $8.6M |
| LLYELI LILLY & Co | 6,681 | $6.1M |
| AMGNAMGEN INC | 15,175 | $5.3M |
| ABTABBOTT LABORATORIES | 49,880 | $5.1M |
| MRKMerck & Co., Inc. | 35,251 | $4.2M |
| PMPhilip Morris International Inc | 11,389 | $1.9M |
| BMYBRISTOL MYERS SQUIBB CO | 26,448 | $1.6M |
| PFEPFIZER INC | 41,109 | $1.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,265 | $613K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.